-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S/O7hxgt/mxgNfDGH7rc5NMPhb7CrMteya4z7bp5zGUesE8TvFPpDwPHHPIy2Ylz kudbqDv4PXHMJXQphl1v9g== 0001169232-09-000961.txt : 20090217 0001169232-09-000961.hdr.sgml : 20090216 20090217104700 ACCESSION NUMBER: 0001169232-09-000961 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20090217 DATE AS OF CHANGE: 20090217 GROUP MEMBERS: BRIAN J. STARK FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ROTH MICHAEL CENTRAL INDEX KEY: 0001010207 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 4142411810 MAIL ADDRESS: STREET 1: 10556 N PORT WASHINGTON RD CITY: MEQUON STATE: WI ZIP: 53092 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Synova Healthcare Group Inc CENTRAL INDEX KEY: 0001316826 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80920 FILM NUMBER: 09608254 BUSINESS ADDRESS: STREET 1: 1400 N PROVIDENCE RD STREET 2: BLDG 2 SUITE 2 CITY: MEDIA STATE: PA ZIP: 19063 BUSINESS PHONE: 610-565-7080 MAIL ADDRESS: STREET 1: 1400 N PROVIDENCE RD STREET 2: BLDG 2 SUITE 2 CITY: MEDIA STATE: PA ZIP: 19063 SC 13G/A 1 d76199_sc13ga.htm AMENDMENT NO. 1

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 13G

 

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN THE STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

(Amendment No. 1)*

Synova Healthcare Group, Inc.

(Name of Issuer)

 

Common Stock, par value $0.001 per share

(Title of Class of Securities)

87163H102

(CUSIP Number)

 

 

December 31, 2008

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o

Rule 13d-1(b)

 

x

Rule 13d-1(c)

 

o

Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


SCHEDULE 13G

CUSIP NO. 87163H102

Page 2 of 5

 

1

 

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

 

Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP         

(a) x
(b)
o

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 


United States of America

NUMBER OF

 

SHARES

 

BENEFICIALLY

 

OWNED BY EACH

 

REPORTING

 

PERSON WITH

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

Common Stock equal to less than 5%

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER


Common Stock equal to less than 5%

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

Common Stock equal to less than 5%

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES               

x

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 


Less than 5%

12

TYPE OF REPORTING PERSON

 

IN


 

SCHEDULE 13G

CUSIP NO. 87163H102

Page 3 of 5

 

Item 1(a).

Name of Issuer:

Synova Healthcare Group, Inc. (the “Issuer”).

 

Item 1(b).

Address of Issuer’s Principal Executive Offices:

1400 North Providence Road, Suite 6010

Media, Pennsylvania 19063

 

Items 2(a),

(b) and (c).

Name of Persons Filing, Address of Principal Business Office and Citizenship:

This Amendment No. 1 to Schedule 13G is being filed on behalf of Michael A. Roth and Brian J. Stark, as joint filers (collectively, the “Reporting Persons”).

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Amendment No. 1 to Schedule 13G as Exhibit 1, pursuant to which the Reporting Persons have agreed to file this Amendment No. 1 to Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

The principal business office of the Reporting Persons is 3600 South Lake Drive, St. Francis, WI 53235. The Reporting Persons are citizens of the United States of America.

Item 2(d).

Title of Class of Securities:

Common Stock, par value $0.001 per share (the “Common Stock”)

 

Item 2(e).

CUSIP Number:

87163H102

Item 3.

Not applicable.

Item 4.

Ownership.

(a)

Amount beneficially owned: Common Stock equal to less than 5%

   

(b)

Percent of class: Less than 5%

   

(c)

Number of shares to which such person has:

   

(i)

Sole power to vote or direct the vote: 0

   

(ii)

Shared power to vote or direct the vote: Common Stock equal to less than 5%

   

(iii)

Sole power to dispose or to direct the disposition of: 0

 

 


SCHEDULE 13G

 

CUSIP NO. 87163H102

Page 4 of 5

 

 

(iv)

Shared power to dispose of or direct the disposition of: Common Stock equal to less than 5%

 

Item 5.

Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported By the Parent Holding Company.

Not applicable

 

Item 8.

Identification and Classification of Members of the Group.

Not applicable

Item 9.

Notice of Dissolution of a Group.

Not applicable

Item 10.

Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 


SCHEDULE 13G

 

CUSIP NO. 87163H102 

Page 5 of 5

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 17, 2009

 

/s/ Michael A. Roth                                       

Michael A. Roth

/s/ Brian J. Stark                                              

Brian J. Stark

 

EX-1 2 d76199_ex-1.htm JOINT FILING AGREEMENT

SCHEDULE 13G

CUSIP NO. 87163H102

Exhibit 1

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to certain shares of Common Stock of Synova Healthcare Group, Inc. and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein; provided, however, that no party is responsible for the completeness or accuracy of the information concerning any other party making the filing, unless such party knows or has reason to believe that such information is inaccurate.

IN WITNESS WHEREOF, the parties have executed this Joint Filing Agreement on February 17, 2009.

 

/s/ Michael A. Roth                                       

Michael A. Roth

/s/ Brian J. Stark                                              

Brian J. Stark

 

-----END PRIVACY-ENHANCED MESSAGE-----